Hashimoto M, Akishita M, Eto M, Kozaki K, Ako J, Sugimoto N, Yoshizumi M, Toba K & Ouchi Y (1998) The impairment of flow-mediated vasodilatation in obese men with visceral fat accumulation. Int J Obes Relat Metab Disord 22, 477–484.
Bergholm R, Tiikkainen M, Vehkavaara S, Tamminen M, Teramo K, Rissanen A & Yki-Jarvinen H (2003) Lowering of LDL cholesterol rather than moderate weight loss improves endothelium-dependent vasodilatation in obese women with previous gestational diabetes. Diabetes Care 26, 1667–1672.
Raitakari M, Ilvonen T, Ahotupa M, Lehtimaki T, Harmoinen A, Suominen P, Elo J, Hartiala J & Raitakari OT (2004) Weight reduction with very-low-caloric diet and endothelial function in overweight adults: role of plasma glucose. Arterioscler Thromb Vasc Biol 24, 124–128.
Fuentes F, Lopez-Miranda J, Sanchez E, et al. (2001) Mediterranean and low-fat diets improve endothelial function in hypercholesterolemic men. Ann Intern Med 134, 1115–1119.
Ros E, Nunez I, Perez-Heras A, Serra M, Gilabert R, Casals E & Deulofeu R (2004) A walnut diet improves endothelial function in hypercholesterolemic subjects: a randomized crossover trial. Circulation 109, 1609–1614.
de Roos NM, Bots ML, Siebelink E, Schouten E & Katan MB (2001) Flow-mediated vasodilation is not impaired when HDL-cholesterol is lowered by substituting carbohydrates for monounsaturated fat. Br J Nutr 86, 181–188.
Keogh JB, Grieger JA, Noakes M & Clifton PM (2005) Flow-mediated dilatation is impaired by a high-saturated fat diet but not by a high-carbohydrate diet. Arterioscler Thromb Vasc Biol 25, 1274–1279.
Poobalan A, Aucott L, Smith WC, Avenell A, Jung R, Broom J & Grant AM (2004) Effects of weight loss in overweight/obese individuals and long-term lipid outcomes – a systematic review. Obes Rev 5, 43–50.
Mensink RP, Zock PL, Kester AD & Katan MB (2003) Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials. Am J Clin Nutr 77, 1146–1155.
Ferri C, Desideri G, Valenti M, Bellini C, Pasin M, Santucci A & De Mattia G (1999) Early upregulation of endothelial adhesion molecules in obese hypertensive men. Hypertension 34, 568–573.
Miller MA & Cappuccio FP (2006) Cellular adhesion molecules and their relationship with measures of obesity and metabolic syndrome in a multiethnic population. Int J Obes (Lond) 30, 1176–1182.
Bemelmans WJ, Lefrandt JD, Feskens EJ, Broer J, Tervaert JW, May JF & Smit AJ (2002) Change in saturated fat intake is associated with progression of carotid and femoral intima-media thickness, and with levels of soluble intercellular adhesion molecule-1. Atherosclerosis 163, 113–120.
Perez-Jimenez F, Castro P, Lopez-Miranda J, et al. (1999) Circulating levels of endothelial function are modulated by dietary monounsaturated fat. Atherosclerosis 145, 351–358.
Ukkola O & Santaniemi M (2002) Adiponectin: a link between excess adiposity and associated comorbidities? J Mol Med 80, 696–702.
Bluher M, Fasshauer M, Tonjes A, Kratzsch J, Schon MR & Paschke R (2005) Association of interleukin-6, C-reactive protein, interleukin-10 and adiponectin plasma concentrations with measures of obesity, insulin sensitivity and glucose metabolism. Exp Clin Endocrinol Diabetes 113, 534–537.
Kopp HP, Krzyzanowska K, Mohlig M, Spranger J, Pfeiffer AF & Schernthaner G (2005) Effects of marked weight loss on plasma levels of adiponectin, markers of chronic subclinical inflammation and insulin resistance in morbidly obese women. Int J Obes (Lond) 29, 766–771.
Monzillo LU, Hamdy O, Horton ES, et al. (2003) Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. Obes Res 11, 1048–1054.
Dvorakova-Lorenzova A, Suchanek P, Havel PJ, Stavek P, Karasova L, Valenta Z, Tintera J & Poledne R (2006) The decrease in C-reactive protein concentration after diet and physical activity induced weight reduction is associated with changes in plasma lipids, but not interleukin-6 or adiponectin. Metabolism 55, 359–365.
Abbasi F, Chu JW, Lamendola C, McLaughlin T, Hayden J, Reaven GM & Reaven PD (2004) Discrimination between obesity and insulin resistance in the relationship with adiponectin. Diabetes 53, 585–590.
Kasim-Karakas SE, Tsodikov A, Singh U & Jialal I (2006) Responses of inflammatory markers to a low-fat, high-carbohydrate diet: effects of energy intake. Am J Clin Nutr 83, 774–779.
Hodge A, Patterson AJ, Brown WJ, Ireland P & Giles G (2000) The Anti Cancer Council of Victoria FFQ: relative validity of nutrient intakes compared with weighed food records in young to middle-aged women in a study of iron supplementation. Aust N Z J Public Health 24, 576–583.
Anderson TJ, Uehata A, Gerhard MD, et al. (1995) Close relation of endothelial function in the human coronary and peripheral circulations. J Am Coll Cardiol 26, 1235–1241.
van Trijp MJ, Beulens JW, Bos WJ, Uiterwaal CS, Grobbee DE, Hendriks HF & Bots ML (2005) Alcohol consumption and augmentation index in healthy young men: the ARYA study. Am J Hypertens 18, 792–796.
Clifton PM, Keogh JB, Foster PR & Noakes M (2005) Effect of weight loss on inflammatory and endothelial markers and FMD using two low-fat diets. Int J Obes (Lond) 29, 1445–1451.
Brook RD, Bard RL, Glazewski L, Kehrer C, Bodary PF, Eitzman DL & Rajagopalan S (2004) Effect of short-term weight loss on the metabolic syndrome and conduit vascular endothelial function in overweight adults. Am J Cardiol 93, 1012–1016.
Hamdy O, Ledbury S, Mullooly C, et al. (2003) Lifestyle modification improves endothelial function in obese subjects with the insulin resistance syndrome. Diabetes Care 26, 2119–2125.
Williams IL, Chowienczyk PJ, Wheatcroft SB, Patel AG, Sherwood RA, Momin A, Shah AM & Kearney MT (2005) Endothelial function and weight loss in obese humans. Obes Surg 15, 1055–1060.
Benjamin EJ, Larson MG, Keyes MJ, et al. (2004) Clinical correlates and heritability of flow-mediated dilation in the community: the Framingham Study. Circulation 109, 613–619.
Steinberg HO, Chaker H, Leaming R, et al. (1996) Obesity/insulin resistance is associated with endothelial dysfunction. J Clin Invest 97, 2601–2610.
Suwaidi JA, Higano ST, Holmes DRJ, et al. (2001) Obesity is independently associated with coronary endothelial dysfunction in patients with normal or mildly diseased coronary arteries. J Am Coll Cardiol 37, 1523–1528.
Nevill AM, Stewart AD, Olds T & Holder R (2006) Relationship between adiposity and body size reveals limitations of BMI. Am J Phys Anthropol 129, 151–156.
Prentice AM & Jebb SA (2001) Beyond body mass index. Obes Rev 3, 141–147.
Abbasi F, Lamendola C, McLaughlin T, Hayden J, Reaven GM & Reaven PD (2004) Plasma adiponectin concentrations do not increase in association with moderate weight loss in insulin-resistant, obese women. Metabolism 53, 280–283.
Pontiroli AE, Pizzocri P, Koprivec D, Vedani P, Marchi M, Arcelloni C, Paroni R, Esposito K & Giugliano D (2004) Body weight and glucose metabolism have a different effect on circulating levels of ICAM-1, E-selectin, and endothelin-1 in humans. Eur J Endocrinol 150, 195–200.
Ziccardi P, Nappo F, Giugliano G, Esposito K, Marfella R, Cioffi M, D'Andrea F, Molinari AM & Giugliano D (2002) Reduction of inflammatory cytokine concentrations and improvement of endothelial functions in obese women after weight loss over one year. Circulation 105, 804–809.
Vazquez LA, Pazos F, Berrazueta JR, Fernandez-Escalante C, Garcia-Unzueta MT, Freijanes J & Amado JA (2005) Effects of changes in body weight and insulin resistance on inflammation and endothelial function in morbid obesity after bariatric surgery. J Clin Endocrinol Metab 90, 316–322.
Shechter M, Freimark D, Beigel R, Matetzky S & Feinberg MS (2006) Short-term sibutramine therapy is associated with weight loss and improved endothelial function in obese patients with coronary artery disease. Am J Cardiol 97, 1650–1653.